Richard Straube

Richard Straube

Plus aucun poste en cours

Fortune : 31 $ au 31/05/2026

74 ans
Health Technology
Consumer Services
Finance

Profil

Richard C.
Straube
worked as Senior Director-Clinical Research & Immunology at Centocor, Inc. from 1988 to 1993.
From 1993 to 1995, served as Director-Medical Affairs at T Cell Sciences, Inc. Between 1995 and 1997, held the position of Director-Clinical Investigations at Ohmeda, Inc. From 1998 to 2007, was Chief Scientific Officer and Executive VP-R&D at INO Therapeutics LLC.
Held the role of Chief Medical Officer at Critical Biologics Corp.
from 2007 to 2009.
From 2009 to 2014, was Chief Medical Officer at Stealth BioTherapeutics, Inc. Served as Chief Medical Officer & Senior Vice President at Soligenix, Inc. from 2014 to 2025.
Also held positions as Faculty Member at the University of California San Diego and Principal at Inomax LLC (Florida).
Education includes a doctorate from The University of Chicago in 1977 and a graduate degree from the London School of Hygiene & Tropical Medicine in 1982.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
11/12/2025 34 ( 0 % ) 31 $ 31/05/2026

Anciens postes connus de Richard Straube

SociétésPosteFin
SOLIGENIX, INC. Directeur Technique/Scientifique/R&D 12/08/2025
Directeur Technique/Scientifique/R&D 01/01/2014
Directeur Technique/Scientifique/R&D 01/01/2009
Directeur Technique/Scientifique/R&D 01/01/2007
Ohmeda, Inc.
Corporate Officer/Principal 02/01/1997
Voir l'expérience en détail de Richard Straube

Formation de Richard Straube

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

91

Relations au 1er degré

11

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées11

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Health Technology

Finance

Ohmeda, Inc.

Health Technology

  1. Bourse
  2. Insiders
  3. Richard Straube
-40% : Prolongation exceptionnelle ➤➤➤➤
j
:
:
PROFITEZ-EN MAINTENANT
🔇